查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018469

青光眼手術醫療設備市場：依手術方法、醫療設備、最終用戶和通路分類－2026-2032年全球市場預測

Glaucoma Surgery Devices Market by Procedure, Device, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年青光眼手術器械市場價值 10 億美元，預計到 2026 年將成長至 10.6 億美元，複合年成長率為 7.40%，到 2032 年將達到 16.5 億美元。

主要市場統計數據
基準年 2025 10億美元
預計年份：2026年 10.6億美元
預測年份 2032 16.5億美元
複合年成長率 (%) 7.40%

本介紹部分概述了推動現代青光眼手術器械決策的臨床需求、器械類型、醫療環境和通路。

青光眼仍然是導致不可逆性視力喪失的主要原因之一，而圍繞手術干預的臨床和商業格局正因人口結構變化、監管趨勢和技術進步而迅速演變。在此背景下，一篇簡明扼要的引言應概述當前形勢，闡述臨床需求、醫療設備創新以及不斷演變的診療路徑之間的相互作用如何影響臨床醫生的選擇和患者的治療結果。

臨床重點、醫療設備創新和不斷變化的採購管道如何相互交織，重新定義青光眼手術的治療流程和商業性競爭。

青光眼手術器械領域正經歷一系列變革，重新定義了臨床診療流程、採購慣例和創新重點。臨床上，人們明顯傾向於選擇併發症率更低、恢復時間更短且可與白內障手術同時進行的手術方式。因此，臨床醫師越來越重視傳統手術方法（如青光眼引流植入和引流管植入術）的長期有效性，以及微創手術方式（如iStent、Kahook雙刃刀、 切除術和XEN凝膠支架）的便利性和良好的圍手術全期期安全性。

2025 年關稅實施後供應鏈重組及其對整個製造和分銷網路的營運、商業和採購的影響。

2025年關稅的實施為眼科手術器械的全球供應鏈和定價策略帶來了新的複雜性。從跨境供應鏈採購關鍵零件和成品的製造商面臨著不斷上漲的投入成本，這往往迫使他們重新評估製造地、供應商合約和產品定價策略。為此，一些公司正在加快關鍵生產流程的在地化進程或實現供應商多元化，以降低風險。另一些公司則選擇暫時承擔增加的成本，以維持市場進入和與臨床醫生的關係。

透過採用詳細的細分觀點，將手術類型、設備類別、醫療環境和分銷管道聯繫起來，我們確定了有針對性的引入途徑和定位機會。

市場細分為詳細分析和市場定位奠定了基礎，多維度的細分方法揭示了每種手術、醫療設備、終端用戶和分銷管道的不同成長促進因素和推廣障礙。根據手術類型，市場可分為傳統手術和微創手術。傳統手術在晚期疾病的治療中仍佔據臨床主導地位，採用青光眼引流植入、切除術和引流管植入等成熟技術。微創手術，包括iStent、Kahook Dual Blade、Trabectome和XEN Gel Stent等平台，由於其安全性和恢復快，在輕度至中度疾病患者以及白內障和青光眼聯合手術中正日益佔據重要地位。

美洲、歐洲、中東和非洲以及亞太地區的區域戰略差異將是決定商業化、循證戰略以及針對每個地區量身定做的供應戰略的因素。

區域趨勢對醫療設備策略、報銷方案和商業化策略的發展至關重要。此外，獨特的區域特徵也造就了獨特的推廣路徑。在美洲，私人和公共保險公司交織的複雜格局、活躍的門診手術中心以及臨床醫生在技術應用方面的高度自主權，共同推動了成熟和新型外科手術解決方案的快速普及，前提是報銷機制清晰明確。

強調臨床證據、綜合服務模式和供應鏈韌性的競爭策略如何重塑企業差異化和夥伴關係活動。

青光眼手術醫療設備領域的企業競爭策略融合了產品漸進式改進、策略夥伴關係以及對實證醫學和臨床醫生培訓的投資。市場參與企業正投入資源改善器械，以提高植入的可重複性、耐用性和安全性，同時也努力建構能夠減輕手術團隊工作量的服務。

為製造商和相關人員提供清晰可行的策略步驟，以加強差異化的商業模式，從而促進證據、供應靈活性和永續採用。

行業領導者應優先採取一系列切實可行的措施，以最大限度地利用當前趨勢，同時降低營運和商業風險。首先，將臨床開發與真實世界證據的優先事項結合，將加速與保險公司的合作以及臨床醫生的採納。有針對性的臨床項目應側重於相對安全且對外科醫生和保險公司都至關重要的生活品質 (QOL) 終點。其次，實現製造地和供應商基礎的多元化（盡可能結合近岸外包）可以降低受關稅成本波動的影響，並提高對區域需求的應對力。

檢驗了研究結果，並確定了其局限性，該設計結合了對臨床醫生的訪談、系統的文獻綜述和三角檢驗分析。

本分析的調查方法融合了定性和定量方法，旨在確保其穩健性、可靠性和對臨床實踐的相關性。主要調查包括對門診手術中心、醫院和眼科診所的外科醫生、採購負責人和臨床負責人進行結構化訪談，以了解手術流程偏好、醫療設備選擇標準和術後管理實踐。

這是一份簡潔而全面的分析報告，它將外科技術的進步、設備差異化和策略需求連結起來。這些因素共同定義了產品推廣應用和永續商業性成功的路徑。

總之，目前青光眼手術器材的發展現況呈現出臨床演變、技術差異化和商業性適應症之間的複雜交互作用。儘管傳統手術方法在晚期疾病中仍然至關重要，但微創手術正在改變早期療育策略和手術全期管理。這些手術趨勢體現在雷射設備、引流管、支架和手術刀片等器械領域，每種器械都有其獨特的臨床意義和實施挑戰。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：青光眼手術醫療設備市場－依手術方式分類

  • 傳統手術
    • 青光眼引流植入
    • 切除術
    • 分流管
  • 微創手術

第9章：青光眼手術醫療設備市場：依器材分類

  • 雷射設備
    • 氬雷射器
    • 選擇性雷射
  • 分流
    • 艾哈邁德閥門
    • 裸帶植入
    • 莫爾特諾植入
  • 支架
    • Hydras 微支架
    • IStent
    • XEN凝膠支架
  • 手術刀片
    • 卡胡克雙刃
    • Trabectome裝置

第10章：青光眼手術醫療設備市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 眼科診所

第11章：青光眼手術醫療設備市場：依分銷管道分類

  • 線上銷售
  • 線下銷售

第12章：青光眼手術醫療設備市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：青光眼手術醫療設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：青光眼手術醫療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國青光眼手術醫療設備市場

第16章：中國青光眼手術醫療設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AbbVie Inc.
  • Alcon Inc.
  • Bausch+Lomb Corporation
  • Beaver-Visitec International
  • Carl Zeiss Meditec AG
  • Ellex Medical Lasers Ltd.
  • Glaukos Corporation
  • iSTAR Medical SA
  • Ivantis, Inc.
  • Johnson & Johnson Vision
  • Lumenis Ltd.
  • MicroSert LLC
  • New World Medical, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Sight Sciences, Inc.
Product Code: MRR-A339DAEF9D8F

The Glaucoma Surgery Devices Market was valued at USD 1.00 billion in 2025 and is projected to grow to USD 1.06 billion in 2026, with a CAGR of 7.40%, reaching USD 1.65 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.00 billion
Estimated Year [2026] USD 1.06 billion
Forecast Year [2032] USD 1.65 billion
CAGR (%) 7.40%

A focused introduction that frames clinical need, device typologies, care settings, and distribution pathways driving contemporary decision-making in glaucoma surgery devices

Glaucoma remains a leading cause of irreversible vision loss, and the clinical and commercial environment for surgical interventions has evolved rapidly in response to demographic pressures, regulatory developments, and technological advances. In this context, a concise introduction must frame the current landscape through the interplay of clinical need, device innovation, and evolving care pathways that influence clinician choice and patient outcomes.

Historically, conventional surgery approaches such as glaucoma drainage implants, trabeculectomy, and tube shunts have formed the backbone of surgical management for advanced disease, while microinvasive surgery options like iStent, Kahook Dual Blade, Trabectome, and XEN Gel Stent have expanded treatment options for earlier-stage disease and combined cataract-glaucoma procedures. These procedural distinctions are mirrored by device typologies that include laser devices subdivided into argon and selective laser modalities, shunts encompassing Ahmed valve, Baerveldt implant, and Molteno implant variants, stents such as Hydrus Microstent, iStent, and XEN Gel Stent, and surgical blades represented by Kahook Dual Blade and Trabectome platforms.

End-user dynamics also shape adoption patterns: ambulatory surgery centers, hospitals, and ophthalmic clinics each present different procedural volumes, reimbursement dynamics, and capital-acquisition models that influence procurement decisions. Distribution channels-including direct sales, online sales, and third-party distributors-further determine how devices reach clinicians and how manufacturers scale geographic coverage. Together, these elements establish the frame for readers to understand the subsequent sections, which examine transformative shifts, trade policy impacts, segmentation nuances, regional differentiators, competitive behaviors, and practical recommendations for industry leaders.

How clinical priorities, device innovation, and shifting procurement channels are converging to redefine treatment algorithms and commercial competition in glaucoma surgery

The landscape for glaucoma surgery devices is undergoing a series of transformative shifts that are redefining clinical algorithms, procurement practices, and innovation priorities. Clinically, there is a clear movement toward procedures that promise lower complication rates, faster recovery times, and compatibility with combined cataract procedures. As a result, clinicians are increasingly balancing the long-established efficacy of conventional surgery approaches such as glaucoma drainage implants, trabeculectomy, and tube shunts against the procedural simplicity and favorable perioperative profiles of microinvasive surgery options like iStent, Kahook Dual Blade, Trabectome, and XEN Gel Stent.

Technological advances are not limited to device miniaturization: laser technologies are differentiating into argon and selective modalities that target specific tissue interactions, while stent and shunt designs are iterating to improve biocompatibility, flow regulation, and implantation reproducibility. Device segmentation that includes laser devices, shunts, stents, and surgical blades is therefore shifting from discrete product families to integrated procedural ecosystems, where device choice is driven as much by system compatibility and surgeon preference as by clinical indication.

Meanwhile, delivery and commercialization models are evolving. Ambulatory surgery centers, hospitals, and ophthalmic clinics exhibit different incentive structures, influencing choice of direct sales relationships, online procurement options, or reliance on third-party distributors. Regulatory scrutiny and reimbursement policy adjustments are prompting manufacturers to prioritize evidence development and real-world outcomes, accelerating adoption pathways where clinical and economic value can be demonstrated. Taken together, these trends are creating a more pluralistic market environment in which multiple approaches coexist, competition is increasingly innovation-led, and market entry requires both clinical credibility and robust commercialization strategy.

The 2025 tariff-driven supply-chain recalibration and its operational, commercial, and procurement implications across manufacturing and distribution networks

The introduction of tariffs in 2025 introduced a new layer of complexity for global supply chains and pricing strategies for ophthalmic surgical devices. Manufacturers that source key components or finished devices from cross-border supply chains have faced increased input costs that, in many cases, require reassessment of manufacturing footprints, supplier contracts, and product pricing strategies. In response, some companies have accelerated localization of critical manufacturing steps or diversified suppliers to mitigate exposure, while others have absorbed incremental costs temporarily to preserve market access and clinician relationships.

These adjustments have had ripple effects across distribution channels and end users. Ambulatory surgery centers, hospitals, and ophthalmic clinics have experienced varying degrees of price sensitivity depending on their reimbursement environments and purchasing models. Where direct sales models predominate, manufacturers have worked closely with procurement teams to tailor pricing, bundling, or service agreements. Where third-party distribution remains important, distributors have had to renegotiate terms and manage inventory strategies to minimize margin compression.

Operationally, tariffs have encouraged a renewed focus on cost-to-serve analyses and total cost of ownership when evaluating devices. Manufacturers are placing higher emphasis on operational efficiency, supply-chain transparency, and post-market support that can justify price positions. At the same time, the policy environment has underscored the strategic importance of regional manufacturing capacities and flexible distribution networks to maintain resilience and responsiveness to clinician demand. Overall, the tariff-driven dynamics have accelerated pragmatic, near-term actions to stabilize supply, while prompting longer-term strategic shifts in where and how devices are produced and delivered.

A granular segmentation-driven perspective linking procedural types, device categories, care settings, and distribution channels to reveal targeted adoption pathways and positioning opportunities

Segmentation provides the scaffolding for nuanced analysis and market positioning, and a multifaceted segmentation approach reveals distinct growth levers and adoption barriers across procedure, device, end user, and distribution channels. Based on procedure, the market divides into conventional surgery and microinvasive surgery. Conventional surgery retains clinical primacy for advanced disease with established techniques such as glaucoma drainage implants, trabeculectomy, and tube shunts. Microinvasive surgery, which includes platforms such as iStent, Kahook Dual Blade, Trabectome, and XEN Gel Stent, is increasingly positioned for patients with mild to moderate disease or for combined cataract-glaucoma procedures because of favorable safety and recovery profiles.

From a device perspective, the landscape encompasses laser devices, shunts, stents, and surgical blades. Laser technologies bifurcate into argon and selective laser approaches that serve different tissue targets and procedural intents. Shunt solutions, including Ahmed valve, Baerveldt implant, and Molteno implant variants, continue to be central to management of refractory glaucoma. Stent technologies such as Hydrus Microstent, iStent, and XEN Gel Stent reflect innovation in minimally invasive outflow augmentation, while surgical blade systems like Kahook Dual Blade and Trabectome devices support tissue resection strategies with different learning curves and intraoperative profiles.

End-user segmentation highlights that ambulatory surgery centers, hospitals, and ophthalmic clinics each present unique adoption environments tied to case mix, capital planning cycles, and care delivery models. Distribution channel segmentation-direct sales, online sales, and third-party distributors-reveals how manufacturers must harmonize sales force strategies, digital channels, and distributor partnerships to ensure product availability, clinician training, and after-sales support. By mapping product innovation to these segmentation axes, stakeholders can identify where clinical needs align with commercial opportunity and where targeted evidence generation will most effectively drive adoption.

Regional strategic differentials across the Americas, Europe, Middle East & Africa, and Asia-Pacific that dictate tailored commercialization, evidence, and supply strategies

Regional dynamics are instrumental in shaping device strategy, reimbursement interactions, and commercialization tactics, and distinct regional characteristics create differentiated pathways to adoption. The Americas exhibit a complex mix of private and public payers, robust ambulatory surgery center activity, and a high degree of clinician autonomy in technology adoption, which together encourage rapid uptake of both established and novel surgical solutions where reimbursement clarity exists.

Europe, Middle East & Africa feature heterogeneous regulatory and reimbursement environments that compel manufacturers to adopt localized evidence strategies and engage payers early. Countries within this region vary considerably in their center-of-excellence models, hospital procurement practices, and emphasis on cost-effectiveness, which affects the sequencing of product launches and the scope of post-market studies required to support broader access.

Asia-Pacific presents a wide spectrum of demand drivers, from aging populations in developed economies to rising procedural volumes and capacity expansion in emerging markets. Local manufacturing and regulatory pathways, along with differing clinician training infrastructures, influence how quickly newer microinvasive technologies are integrated into standard practice. Across all regions, distribution channel dynamics and tariff-related considerations intersect with regional regulatory pressures to shape launch timing, pricing strategies, and clinician engagement plans.

How competitive strategies emphasizing clinical evidence, integrated service models, and supply-chain resilience are reshaping company differentiation and partnership activity

Competitive behavior among companies in the glaucoma surgery devices space reflects a mix of incremental product refinement, strategic partnerships, and investments in evidence generation and clinician training. Market participants are channeling resources toward device improvements that address implantation reproducibility, durability, and safety profiles, while simultaneously building services that reduce the operational burden on surgical teams.

Some firms are prioritizing integrated value propositions that combine device supply with procedural training, digital support tools, and patient follow-up platforms to demonstrate real-world outcomes and cost-to-serve advantages. Others are focusing on geographic expansion by strengthening distributor relationships or establishing regional manufacturing to reduce lead times and tariff exposure. Collaborations between device innovators and established surgical companies are becoming more common as a means to scale access quickly while leveraging established sales and training infrastructures.

Across these behaviors, the common thread is an emphasis on clinical evidence and post-market surveillance to support payer engagement and clinician confidence. Companies that align R&D priorities with clear end-user needs-hospital procurement dynamics, ambulatory surgery center workflows, or ophthalmic clinic constraints-tend to achieve more coherent adoption trajectories. Ultimately, competitive differentiation is increasingly defined by the ability to offer reproducible clinical outcomes, streamlined training, and supply-chain reliability rather than by product features alone.

Clear, practical strategic moves for manufacturers and stakeholders to strengthen evidence, supply agility, and differentiated commercial models that drive durable adoption

Industry leaders should prioritize a set of actionable initiatives to capitalize on current trends while mitigating operational and commercial risks. First, aligning clinical development with real-world evidence priorities will accelerate payer engagement and clinician uptake; targeted clinical programs should emphasize comparative safety and quality-of-life endpoints that matter to both surgeons and payers. Second, diversifying manufacturing and supplier bases-paired with nearshoring where feasible-will reduce exposure to tariff-driven cost volatility and improve responsiveness to regional demand.

Third, manufacturers should invest in tailored go-to-market strategies that reflect differences across ambulatory surgery centers, hospitals, and ophthalmic clinics, ensuring that training, reimbursement support, and service models are adapted to each setting. Fourth, distribution strategies must be deliberately hybrid: robust direct-sales relationships in high-touch specialty centers, complemented by digital channels and third-party distributors for broader geographic coverage and efficiency gains. Fifth, companies should consider bundling devices with digital follow-up tools or managed services to demonstrate total cost of care benefits and differentiate on value.

Finally, forging strategic partnerships-whether for co-development, training networks, or regional commercialization-can accelerate access while sharing implementation risk. By operationalizing these recommendations, industry leaders can build resilient commercialization plans that align product innovation with practical adoption pathways and payer expectations.

A rigorous mixed-methods research design combining clinician interviews, systematic literature review, and triangulated analysis to validate findings and highlight limitations

The research methodology underpinning this analysis integrates qualitative and quantitative approaches designed to ensure robustness, reliability, and practitioner relevance. Primary research included structured interviews with surgeons, procurement officers, and clinical leaders across ambulatory surgery centers, hospitals, and ophthalmic clinics to capture procedural preferences, device selection criteria, and post-operative management practices.

Secondary research involved systematic review of peer-reviewed clinical literature, regulatory filings, device labeling, and industry publications to contextualize technological developments across laser devices, shunts, stents, and surgical blades. Data were triangulated through cross-validation between primary respondent insights and secondary sources to reduce bias and identify consistent patterns. Segmentation mapping was applied to align procedural categories such as conventional surgery and microinvasive surgery with device archetypes and end-user behaviors.

Analytical techniques included thematic synthesis for qualitative inputs and scenario analysis for supply-chain and tariff impacts. Quality controls included respondent validation, where key findings were reviewed with a subset of interviewees for accuracy, and methodological transparency, with clear documentation of data sources, inclusion criteria, and any limitations. This layered approach ensured that conclusions reflect both frontline clinical practice and broader technology and policy dynamics.

A concise synthesis linking procedural evolution, device differentiation, and strategic imperatives that together define pathways to adoption and sustainable commercial success

In conclusion, the glaucoma surgery devices landscape is defined by a complex interplay of clinical evolution, technological differentiation, and commercial adaptation. Conventional surgical approaches maintain an indispensable role for advanced disease, while microinvasive options are reshaping earlier intervention strategies and perioperative management. These procedural dynamics are mirrored by device segmentation across laser devices, shunts, stents, and surgical blades, each with distinct clinical rationales and adoption challenges.

Regional and policy developments, including tariff-related supply-chain adjustments, have underscored the importance of manufacturing flexibility, distribution agility, and evidence-led commercialization. End users-ambulatory surgery centers, hospitals, and ophthalmic clinics-each demand tailored engagement models that reflect procedural mixes, procurement cycles, and training requirements. Competitive differentiation increasingly hinges on demonstrable real-world outcomes, reproducible implantation techniques, and integrated support services rather than product attributes alone.

Looking ahead, stakeholders that combine targeted clinical evidence generation, resilient supply-chain strategies, and nuanced go-to-market execution will be best positioned to convert innovation into sustained clinical adoption and commercial success. This synthesis provides a practical basis for planning next steps across product development, market entry, and organizational investments.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Glaucoma Surgery Devices Market, by Procedure

  • 8.1. Conventional Surgery
    • 8.1.1. Glaucoma Drainage Implants
    • 8.1.2. Trabeculectomy
    • 8.1.3. Tube Shunts
  • 8.2. Microinvasive Surgery

9. Glaucoma Surgery Devices Market, by Device

  • 9.1. Laser Devices
    • 9.1.1. Argon Laser
    • 9.1.2. Selective Laser
  • 9.2. Shunts
    • 9.2.1. Ahmed Valve
    • 9.2.2. Baerveldt Implant
    • 9.2.3. Molteno Implant
  • 9.3. Stents
    • 9.3.1. Hydrus Microstent
    • 9.3.2. IStent
    • 9.3.3. XEN Gel Stent
  • 9.4. Surgical Blades
    • 9.4.1. Kahook Dual Blade
    • 9.4.2. Trabectome Device

10. Glaucoma Surgery Devices Market, by End User

  • 10.1. Ambulatory Surgery Centers
  • 10.2. Hospitals
  • 10.3. Ophthalmic Clinics

11. Glaucoma Surgery Devices Market, by Distribution Channel

  • 11.1. Online Sales
  • 11.2. Offline Sales

12. Glaucoma Surgery Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Glaucoma Surgery Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Glaucoma Surgery Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Glaucoma Surgery Devices Market

16. China Glaucoma Surgery Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. AbbVie Inc.
  • 17.6. Alcon Inc.
  • 17.7. Bausch + Lomb Corporation
  • 17.8. Beaver-Visitec International
  • 17.9. Carl Zeiss Meditec AG
  • 17.10. Ellex Medical Lasers Ltd.
  • 17.11. Glaukos Corporation
  • 17.12. iSTAR Medical SA
  • 17.13. Ivantis, Inc.
  • 17.14. Johnson & Johnson Vision
  • 17.15. Lumenis Ltd.
  • 17.16. MicroSert LLC
  • 17.17. New World Medical, Inc.
  • 17.18. Santen Pharmaceutical Co., Ltd.
  • 17.19. Sight Sciences, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GLAUCOMA SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TUBE SHUNTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TUBE SHUNTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TUBE SHUNTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICROINVASIVE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ARGON LASER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ARGON LASER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ARGON LASER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SELECTIVE LASER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SELECTIVE LASER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SELECTIVE LASER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AHMED VALVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AHMED VALVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AHMED VALVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY BAERVELDT IMPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY BAERVELDT IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY BAERVELDT IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MOLTENO IMPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MOLTENO IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MOLTENO IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HYDRUS MICROSTENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HYDRUS MICROSTENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HYDRUS MICROSTENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OFFLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OFFLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OFFLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. GCC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. GCC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 177. GCC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 178. GCC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 179. GCC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 180. GCC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 181. GCC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 182. GCC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2032 (USD MILLION)
  • TABLE 183. GCC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. GCC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 205. G7 GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. G7 GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 207. G7 GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 208. G7 GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 209. G7 GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 210. G7 GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 211. G7 GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 212. G7 GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2032 (USD MILLION)
  • TABLE 213. G7 GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. G7 GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. NATO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. NATO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 217. NATO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 218. NATO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 219. NATO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 220. NATO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 221. NATO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 222. NATO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2032 (USD MILLION)
  • TABLE 223. NATO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. NATO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CONVENTIONAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY LASER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SHUNTS, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGICAL BLADES, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)